Search Results

The Role of the MyD88/IL-1/IL-1R Signaling Axis and TLR1 Expression in Breast Cancer (MCF7) Cells.

• Authors : Hassoon, Rasha Amer¹ ; froushani, Seyyed Meysam Abtahi¹; Razi, Mazdak²

• Source: Journal of Neonatal Surgery. 2025 Supplement, Vol. 14, p931-934. 4p.

Record details

The Evolving Landscape Of Breast Cancer Treatment: From Conventional Approaches To Emerging Innovations.

• Authors : Kamal, Preeti¹; Ansari, Zeeshan¹; Neha¹

• Source: Journal of Neonatal Surgery. 2025 Supplement, Vol. 14, p1660-1673. 14p.

Record details

Comparative Study of Cardiac Radiation Dose With Different Types of Surgery in Breast Cancer Patients.

• Authors : Khairullah Al-Maliki, Sajjad Abbas¹ ; Mussttaf, Alaa Hasan²; Desher Al-Haidary, Yahya Ali³

Subjects: *Breast cancer surgery; *Breast cancer; *Dose fractionation

• Source: Diyala Journal of Medicine. Dec2024, Vol. 27 Issue 2, p53-64. 12p.

Record details

Knockdown of NEIL3 inhibits the growth of breast cancer cells by mediating the PI3K/Akt/mTOR axis.

• Authors : Wanqiong Zheng¹ ; Ye Tian²; Yiming Zhang¹

• Source: European Journal of Gynaecological Oncology. Mar2025, Vol. 46 Issue 3, p105-111. 7p.

Record details

Invasive micropapillary type male breast cancer: a case report.

• Authors : Acar, Muhammet Sefa¹ ; Şimşek, Sercan²; Urfali, Furkan Ertürk³

• Source: European Research Journal. Sep2024, Vol. 10 Issue 5, p544-549. 6p.

Record details

Harnessing Computational Drug Design for Innovative Breast Cancer Therapeutics.

• Authors : Saumya Das, Shruti Aggarwal¹ ; Tushar Chaudhary, Priyanka Bansal²

• Source: Journal of Neonatal Surgery. 2025 Supplement, Vol. 14, p961-978. 18p.

Record details

RAS/RAF/MEK/MAPK signaling pathway as a therapeutic target in breast cancer: Emphasis on a novel carrier for tamoxifen and digestion behaviors.

• Authors : Mansouri, Niloofar¹; Daneshgar, Melika¹; Khojasteh, Farzaneh¹

• Source: Avicenna Journal of Phytomedicine. May/Jun2025, Vol. 15 Issue 3, p1204-1227. 24p.

Record details

Evaluation of Adverse Drug Reactions (ADRs) in Breast Cancer Patients Who Received Doxorubicin, Cyclophosphamide (AC) and Doxorubicin, Cyclophosphamide, Paclitaxel (AC-T) Chemotherapy at West Nusa Tenggara Provincial Hospital.

• Authors : Baiq Lenysia Puspita Anjani¹ ; Rahma Nanda Muriani¹; Baiq Nurbaety¹

• Source: Pharmacy & Pharmaceutical Sciences Journal / Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia. Aug2024, Vol. 11 Issue 2, p253-259. 7p.

Record details

Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life.

• Authors : Rusli, Emelly¹ ; Wujcik, Debra¹; Galaznik, Aaron¹

• Source: Bioengineering (Basel). Aug2024, Vol. 11 Issue 8, p846. 15p.

Record details

Geriatric Breast Cancer: Staging, Molecular Surrogates, and Treatment. A Review & Meta-analysis.

• Authors : Fonseca, Vasco C.¹ ; Sidiropoulou, Zacharoula²

• Source: Aging & Disease. Aug2024, Vol. 15 Issue 4, p1602-1618. 17p.

Record details